High-concentration local TXA impairs random-pattern flap survival, while low-concentration TXA (10 mg/mL) appears well tolerated, while the surgical delay procedure markedly reduces TXA-associated necrosis risk across all concentrations.
Abstract
Background
Random-pattern skin flaps are prone to distal necrosis, a major challenge in reconstructive surgery. Tranexamic acid (TXA) reduces perioperative bleeding, but its impact on flap viability remains controversial.
Objectives
To investigate the concentration-dependent effects of local TXA application on random-pattern flap survival, with and without surgical delay, in the McFarlane dorsal rat flap model.
Methods
Sixty-four female Wistar albino rats were randomized into eight groups (n=8): control, TXA 10, 30, and 100 mg/mL, delayed control, and delayed TXA at the same concentrations. A 3×9 cm caudal-based dorsal flap was elevated and 1 mL of saline or TXA was administered locally before closure. Flap necrosis was quantified using ImageJ software. Two-way ANOVA assessed the independent effects of delay and TXA concentration; subgroup analyses used one-way ANOVA with Tukey HSD (non-delayed) and Kruskal-Wallis with Dunn's test (delayed).
Results
High-concentration TXA (100 mg/mL) significantly increased necrosis in non-delayed flaps (40.39% ± 7.41%, p = 0.016 vs. control). Delayed flaps showed markedly reduced necrosis across all groups (delayed control: 1.00% ± 1.45%, p < 0.001). No significant differences were observed among delayed subgroups regardless of TXA concentration. Two-way ANOVA identified the delay procedure as the dominant main effect (F(1,56) = 665.97, p < 0.001, partial η2 = 0.922).
Conclusions
High-concentration local TXA impairs random-pattern flap survival, while low-concentration TXA (10 mg/mL) appears well tolerated. The surgical delay procedure markedly reduces TXA-associated necrosis risk across all concentrations. Careful concentration selection is recommended when TXA is used in cutaneous flap surgery.
OBJECTIVE
Tranexamic acid (TXA) is an antifibrinolytic agent studied for its role in reducing perioperative bleeding. While it has shown promise in operations requiring free tissue transfer in plastic surgery, its application in head and neck free flap reconstruction is less documented. This study evaluates the impact...
Gabrielle-Jaquelline Adams, I. Fried, G. A. Longfellow et al.· The Laryngoscope· 0 citations
BACKGROUND
Tranexamic acid (TXA) reduces perioperative blood loss in several surgical fields; however, its role in breast reduction surgery remains unclear. This study aimed to evaluate the effect of combined TXA therapy (intravenous and local infiltration) on postoperative outcomes of patients who underwent modified L...
M. Silva, Pedro Machado, A. S. Barros et al.· Aesthetic Plastic Surgery· 0 citations
To evaluate the analgesic efficacy, safety, and clinical value of liposomal bupivacaine for pain management following immediate dental implant surgery.
This prospective, single-center, two-group, parallel-arm superiority randomized controlled trial was registered at [ISRCTN](registration number: redacted...
Shi-Lei Han, Na Li· Journal of Oral Implantology· 0 citations
BACKGROUND
Postoperative bleeding and prolonged drainage remain relevant complications in soft tissue surgery and may result in revision surgery, extended hospital stay, and increased morbidity. Topical tranexamic acid (TXA), a synthetic lysine analog with antifibrinolytic effects, has gained increasing attention as a...
Georg Oppolzer, L. Steinkellner, Nadalina Sifkovits et al.· Annals of Plastic Surgery· 0 citations
Photobiomodulation (PBM) has been proposed as a non-invasive therapeutic strategy to support wound healing and modulate oxidative and inflammatory responses. However, clinical data evaluating its effects in the postoperative period of abdominoplasty remain limited. This non-randomized clinical trial included 31 female...
Carmen Lucia Kretiska Araujo, G. Fardin, Ana Paula Bernardi et al.· Lasers in Medical Science· 0 citations
Is your company’s AI sovereign? A practical guide for CIOs on AI vendor lock-in, EU Data Act switching, cloud sovereignty, and testing your exit plan before you need it. The post Sovereignty Is the Option to Leave appeared first on GPT-Lab.
Microsoft Research Blog· microsoft.comOct 30, 2026
Evaluating Microsoft Copilot at enterprise scale requires test data that captures the full complexity of real organizations, yet real enterprise data contains sensitive information that cannot be used for evaluation under any circumstances. The post From synthetic enterprise data evaluations to real Microsoft Copilot AI confidence appeared first on Microsoft Research.
Microsoft Research Blog· microsoft.comOct 29, 2026
Host Sowbhagya Suresh shares some of the latest news and cutting-edge research from across Microsoft—from understanding the challenges facing coding agents to uncovering how people use AI at work and improving extended-range weather forecasting. The post Microsoft Research Focus – Edition #97 appeared first on Microsoft Research.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.